Our Team
ANA MINGORANCE PHd
chief OF translational science
A neuroscientist, Ana has worked in drug development for epilepsy and neurodevelopmental syndromes for 15 years, first at UCB Pharma and later as an independent consultant to biotech and pharma companies. She has supported numerous therapeutic programs across different stages, including three currently approved drugs. She is also the Chief Development Officer of the Loulou Foundation (for CDKL5 Deficiency Disorder), former Scientific Director of the Dravet Syndrome Foundation Spain, and an advisor to other rare disease foundations.
Ana earned her PhD in neuroscience from the University of Barcelona in Spain and completed an EMBO postdoctoral fellowship at the University of British Columbia in Vancouver.
Trish davidson
project manager
Trish Davidson holds a Masters in Public Administration from the University of South Carolina and has worked in patient advocacy and patient engagement for over 20 years, primarily leading research initiatives, public-private partnerships and patient education and support. Trish is currently an independent consultant facilitating the development of public-private partnerships and supporting the creation and management of consortia. In this capacity, Trish supports the management of the CureSHANK Biomarkers and Outcome Measures Consortium.